On September 29, 2009
Medicis’ Solodyn Sales Stay Strong Despite Generic Challenges; Pay-to-Delay Works
Despite both Teva and Sandoz dipping their generic toes into the Solodyn acne franchise, sales of Medicis’ pimple-popper are still going up. Why? Because Medicis has paid most of those rivals to stop making their versions of the drug.
0 Comments